Peer Review reports
From: Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
| Original Submission | ||
|---|---|---|
| 1 Jul 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 28 Nov 2021 | Reviewed | Reviewer Report |
| 21 Dec 2021 | Reviewed | Reviewer Report - Akin Cakir |
| 26 Dec 2021 | Reviewed | Reviewer Report |
| 1 Jan 2022 | Reviewed | Reviewer Report |
| 8 Jan 2022 | Author responded | Author comments - Qionglei Zhong |
| Resubmission - Version 4 | ||
| 8 Jan 2022 | Submitted | Manuscript version 4 |
| 18 Jan 2022 | Author responded | Author comments - Qionglei Zhong |
| Resubmission - Version 5 | ||
| 18 Jan 2022 | Submitted | Manuscript version 5 |
| 28 Jan 2022 | Author responded | Author comments - Qionglei Zhong |
| Resubmission - Version 6 | ||
| 28 Jan 2022 | Submitted | Manuscript version 6 |
| 16 Feb 2022 | Author responded | Author comments - Qionglei Zhong |
| Resubmission - Version 7 | ||
| 16 Feb 2022 | Submitted | Manuscript version 7 |
| 7 Mar 2022 | Author responded | Author comments - Qionglei Zhong |
| Resubmission - Version 8 | ||
| 7 Mar 2022 | Submitted | Manuscript version 8 |
| 10 Mar 2022 | Reviewed | Reviewer Report |
| 13 Mar 2022 | Reviewed | Reviewer Report |
| 20 May 2022 | Author responded | Author comments - Qionglei Zhong |
| Resubmission - Version 9 | ||
| 20 May 2022 | Submitted | Manuscript version 9 |
| 26 May 2022 | Reviewed | Reviewer Report |
| 26 May 2022 | Reviewed | Reviewer Report |
| 28 May 2022 | Author responded | Author comments - Qionglei Zhong |
| Resubmission - Version 10 | ||
| 28 May 2022 | Submitted | Manuscript version 10 |
| Publishing | ||
| 9 Jun 2022 | Editorially accepted | |
| 21 Jun 2022 | Article published | 10.1186/s12886-022-02489-6 |
You can find further information about peer review here.